Fluticasone propionate/salmeterol
Fluticasone propionate/salmeterol is a combination medication used in the management and prevention of asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: fluticasone propionate, a corticosteroid, and salmeterol, a long-acting beta-2 agonist.
Composition[edit | edit source]
Fluticasone propionate/salmeterol consists of two components. Fluticasone propionate is a synthetic corticosteroid that exhibits potent anti-inflammatory activity. Salmeterol is a selective long-acting beta-2 adrenoceptor agonist with a long duration of action. It is used for its bronchodilator effect.
Mechanism of Action[edit | edit source]
Fluticasone propionate works by reducing the swelling and inflammation in the airways, making it easier to breathe. Salmeterol works by relaxing the muscles in the walls of the small air passages in the lungs, helping to keep the airways open and making it easier to breathe.
Indications[edit | edit source]
Fluticasone propionate/salmeterol is indicated for the long-term, twice-daily (morning and evening) administration in the maintenance treatment of asthma and in the prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease, including patients with symptoms of nocturnal asthma.
Side Effects[edit | edit source]
Common side effects of fluticasone propionate/salmeterol include headache, throat irritation, and upper respiratory tract infection. Serious side effects may include an increased risk of pneumonia, glaucoma, and cataracts.
Contraindications[edit | edit source]
Fluticasone propionate/salmeterol is contraindicated in patients with hypersensitivity to any of the ingredients in the product. It should not be used in patients with status asthmaticus or acute episodes of asthma or COPD requiring intensive measures.
Interactions[edit | edit source]
Fluticasone propionate/salmeterol may interact with other drugs including beta-blockers, diuretics, and MAO inhibitors. It is important to inform the healthcare provider of all the medications a patient is taking.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD